Core Insights - Blackstone Secured Lending Fund reported revenue of $357.76 million for the quarter ended March 2025, reflecting a year-over-year increase of 17.7% [1] - The earnings per share (EPS) for the quarter was $0.83, slightly down from $0.87 in the same quarter last year [1] - The revenue exceeded the Zacks Consensus Estimate by 0.94%, while the EPS also surpassed the consensus estimate by 1.22% [1] Financial Performance Metrics - Fee income was reported at $0.73 million, which was below the average estimate of $1.17 million from three analysts [4] - Interest income reached $335.69 million, exceeding the two-analyst average estimate of $330.05 million [4] - Payment-in-kind interest income was $21.35 million, surpassing the average estimate of $19 million based on two analysts [4] Stock Performance - Over the past month, shares of Blackstone Secured Lending Fund returned +9.6%, compared to a +10.6% change in the Zacks S&P 500 composite [3] - The stock currently holds a Zacks Rank 3 (Hold), indicating expected performance in line with the broader market in the near term [3]

For the quarter ended March 2025, Canadian National (CNI) reported revenue of $3.07 billion, down 2.7% over the same period last year. EPS came in at $1.29, compared to $1.28 in the year-ago quarter.The reported revenue compares to the Zacks Consensus Estimate of $3.11 billion, representing a surprise of -1.32%. The company delivered an EPS surprise of +2.38%, with the consensus EPS estimate being $1.26.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and h ...

Core Insights - BJ's Restaurants reported revenue of $347.97 million for the quarter ended March 2025, reflecting a 3.2% increase year-over-year [1] - The company's EPS was $0.59, significantly higher than $0.32 in the same quarter last year, indicating a strong performance [1] - BJ's revenue slightly exceeded the Zacks Consensus Estimate of $347.94 million, resulting in a surprise of +0.01% [1] - The EPS surprise was notable at +47.50%, compared to the consensus estimate of $0.40 [1] Financial Performance Metrics - Comparable restaurant sales increased by 1.7%, which was below the average estimate of 2.1% from seven analysts [4] - The total number of restaurants remained at 219, matching the six-analyst average estimate [4] - Restaurant operating weeks totaled 2,835, slightly below the average estimate of 2,837 from four analysts [4] - Only one new restaurant was opened, consistent with the two-analyst average estimate of 1 [4] Stock Performance - Over the past month, BJ's Restaurants' shares have returned -7.1%, compared to a -0.7% change in the Zacks S&P 500 composite [3] - The stock currently holds a Zacks Rank 3 (Hold), suggesting it may perform in line with the broader market in the near term [3]

Leonardo DRS, Inc. (DRS) reported $799 million in revenue for the quarter ended March 2025, representing a year-over-year increase of 16.1%. EPS of $0.20 for the same period compares to $0.14 a year ago.The reported revenue represents a surprise of +7.32% over the Zacks Consensus Estimate of $744.53 million. With the consensus EPS estimate being $0.17, the EPS surprise was +17.65%.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall ...

Core Insights - Onity Group reported $249.8 million in revenue for Q1 2025, a year-over-year increase of 4.5% and an EPS of $2.84 compared to $1.74 a year ago, indicating strong earnings growth [1] - The revenue fell short of the Zacks Consensus Estimate of $259.96 million, resulting in a surprise of -3.91%, while the EPS exceeded expectations by +58.66% against a consensus estimate of $1.79 [1] - Onity's stock has returned +10.1% over the past month, outperforming the Zacks S&P 500 composite's -0.2% change, and currently holds a Zacks Rank 2 (Buy) [3] Financial Metrics - Servicing and subservicing fees were reported at $203.30 million, below the average estimate of $218.71 million [4] - Other revenues amounted to $10.90 million, slightly below the estimated $10.99 million [4] - Gain on loans held for sale, net, was $11.80 million, compared to the average estimate of $12.45 million [4] - Gain on reverse loans held for investment and HMBS-related borrowings, net, was $23.80 million, exceeding the average estimate of $17.86 million [4]

Core Insights - Stepan Co. reported revenue of $593.26 million for Q1 2025, a 7.6% year-over-year increase, with an EPS of $0.84 compared to $0.64 a year ago [1] - The revenue exceeded the Zacks Consensus Estimate of $558.6 million by 6.20%, and the EPS surpassed the consensus estimate of $0.51 by 64.71% [1] Financial Performance Metrics - Specialty Products net sales were $16.80 million, exceeding the estimated $16.50 million, reflecting an 11.4% increase year-over-year [4] - Polymers net sales reached $146.12 million, slightly above the estimated $138.70 million, with a year-over-year increase of 0.4% [4] - Surfactants net sales amounted to $430.34 million, surpassing the estimated $403.45 million, marking a 10.1% year-over-year increase [4] - Operating income for Surfactants was $28.93 million, exceeding the average estimate of $25.90 million [4] - Operating income for Specialty Products was $5.51 million, above the average estimate of $3.70 million [4] - Operating income for Polymers was $8.02 million, below the average estimate of $11.25 million [4] Stock Performance - Stepan Co. shares have returned -12.5% over the past month, compared to a -0.8% change in the Zacks S&P 500 composite [3] - The stock currently holds a Zacks Rank 5 (Strong Sell), indicating potential underperformance relative to the broader market in the near term [3]

Core Insights - Revvity (RVTY) reported revenue of $664.76 million for the quarter ended March 2025, reflecting a 2.3% increase year-over-year and a surprise of +0.39% over the Zacks Consensus Estimate of $662.17 million [1] - The company's EPS for the quarter was $1.01, up from $0.98 in the same quarter last year, resulting in an EPS surprise of +5.21% compared to the consensus estimate of $0.96 [1] Revenue and Earnings Performance - Organic revenue growth in Life Sciences was 2%, below the average estimate of 6.1% from three analysts [4] - Total organic revenue growth was reported at 4%, exceeding the average estimate of 3.6% from three analysts [4] - Organic revenue growth in Diagnostics was 5%, significantly higher than the average estimate of 1.5% from three analysts [4] Sales Metrics - Net Sales in Life Sciences reached $340.40 million, slightly above the average estimate of $338.13 million from three analysts, with a year-over-year change of +12.3% [4] - Net Sales in Diagnostics were reported at $324.37 million, slightly below the average estimate of $324.78 million from three analysts, representing a year-over-year decline of -6.6% [4] Stock Performance - Revvity's shares have returned -10.7% over the past month, compared to a -4.3% change in the Zacks S&P 500 composite [3] - The stock currently holds a Zacks Rank 3 (Hold), indicating potential performance in line with the broader market in the near term [3]

Financial Performance - Washington Trust Bancorp reported revenue of $59.07 million for the quarter ended March 2025, representing a 21% increase year-over-year [1] - The earnings per share (EPS) for the quarter was $0.61, a slight decrease from $0.64 in the same quarter last year [1] - The reported revenue exceeded the Zacks Consensus Estimate of $52.98 million by 11.50%, while the EPS fell short of the consensus estimate of $0.62 by 1.61% [1] Key Metrics - The net interest margin was reported at 2.3%, matching the average estimate from two analysts [4] - The efficiency ratio was 71.4%, higher than the estimated 69.5% by two analysts [4] - Total noninterest income was $22.64 million, significantly above the estimated $16.28 million [4] - Net interest income was reported at $36.42 million, slightly below the average estimate of $36.69 million [4] Stock Performance - Over the past month, shares of Washington Trust have returned -13.1%, compared to a -5.6% change in the Zacks S&P 500 composite [3] - The stock currently holds a Zacks Rank 3 (Hold), indicating expected performance in line with the broader market in the near term [3]